This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Chronic kidney disease
  • /
  • Clinical Practice Guideline Anaemia of Chronic Kid...
Guideline

Clinical Practice Guideline Anaemia of Chronic Kidney Disease

Read time: 1 mins
Last updated:1st Feb 2020
Status: Live
Clinical Practice Guideline Anaemia of Chronic Kidney Disease - The UK Kidney Association


This clinical practice guideline provides recommendations on the management of anaemia of chronic kidney disease (ACKD) and serves as an update of the 5th edition module published online in 2010.

This guideline update covers the management of anaemia in adults, children and young people with anaemia associated with CKD.

Anaemia is a common complication of CKD. It is associated with left ventricular dysfunction and heart failure, in addition to a reduction in exercise capacity and quality of life. The use of iron therapies and erythropoiesis stimulating agents (ESAs) has allowed improvement in patients with anaemia of CKD. Newer therapies are under study, but this guideline will not make recommendations on agents such as hypoxia inducible factor stabilisers or hepcidin modulators as data remains preliminary and none of these agents have received a UK marketing authorisation at the time of publication of this guideline.


Read full Guideline